Comparison of Clinical Status of Individuals With COPD and Preserved Ratio Impaired Spirometry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorHacettepe University
About this trial
Despite the globally varying high prevalence rate of the PRISm phenotype, there are no guidelines for its diagnostic evaluation and management. Further studies are needed on appropriate approaches for individuals with PRISm to improve respiratory symptoms and prognosis. As research continues to evolve, PRISm needs to be recognized as a critical component of pulmonary assessments and at-risk individuals need to be provided with appropriate treatment and follow-up to prevent progression to COPD. There are no studies in the literature comparing PRISm, respiratory muscle strength, peripheral muscle strength and oxygenation, arterial stiffness, physical activity level and sleep level in COPD and healthy individuals. The aim of this study was to compare respiratory muscle strength, peripheral muscle strength and oxygenation, arterial stiffness, physical activity level and sleep level in PRISm, COPD and healthy subjects.
Eligibility criteria
Qualifiers
Being >40 years old,
Being diagnosed with PRISm,
Volunteering to participate in the study,
Not having any orthopaedic or neurological problems that may prevent participation in the measurements,
Disqualifiers
Being diagnosed with COPD,
Severe orthopaedic, neurological and cardiac diseases
Not volunteering to participate in the study
Severe orthopaedic, neurological and cardiac diseases,
Trial design
Treatments tested in this trial
- Not listed
Trial groups
54 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov